siRNA treatment lowers triglycerides in individuals along with uncommon disorder

.ANALYSIS HIGHLIGHT.19 September 2024.

Plozasiran lessened triglyceride levels through 80% and reduced the danger of pancreatitis in patients with constant chylomicronemia, with or without a genetic prognosis.